+91 9650760803 
|🩺 Reviewed By:Tabish Iqbal|
Published: June 14, 2020 | Updated: June 12, 2026
Key Takeaways
- 01. Treatment offered in India:
The centre provides mesenchymal and hematopoietic stem cell therapies in Delhi for patients with Parkinson’s disease. - 02. Intended benefit:
The therapy aims to reduce inflammation, regenerate dopaminergic neurons, and improve motor symptoms such as tremor, rigidity, and gait. - 03. Evidence status:
The article notes that the therapy remains experimental, outcomes vary, and no major regulatory body (such as the FDA) has approved it yet. - 04. Patient factors and context:
Results depend on disease stage, stem cell type, delivery method, and overall health. Continuing standard medical therapies and diagnostics is advised alongside any stem cell treatment.
Parkinson’s Disease — Overview
Parkinson’s disease is a progressive neurodegenerative disorder that often affects movement — caused by loss of dopamine-producing neurons in the substantia nigra, a brain region controlling motor control. As neurons decline, patients develop tremor, stiffness, slowness of movement, and balance problems that impair daily activities and independence.
Current therapies can manage symptoms and improve quality of life but cannot reverse neuronal loss. Stem cell therapy offers regenerative potential by replacing damaged dopaminergic neurons and supporting neural circuits to improve motor function.
At Viezec, our regenerative medicine protocols aim to protect, repair, and rejuvenate neural tissues using safe and ethical stem cell applications — focused on long-term motor preservation and neurological recovery.
How Stem Cells Help in Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder caused by the loss of dopamine-producing neurons in the brain. As these nerve cells deteriorate, patients experience tremors, stiffness, slowness of movement, and balance problems that affect mobility and daily activities. The ongoing neurodegeneration reduces independence and quality of life over time.
Stem cell therapy, especially using mesenchymal stem cells (MSCs), offers neuroprotective and regenerative support by replacing damaged neurons and enhancing dopamine signaling. MSCs release growth factors that reduce inflammation, protect existing nerve cells, and help restore neural communication — offering hope for functional improvement in Parkinson’s patients.
Causes of Parkinson’s Disease Explained
Parkinson’s disease results from progressive loss of dopamine-producing neurons in the brain, caused by a mix of genetic, environmental, and cellular processes that impair movement control and other neurological functions. Early identification of contributing factors supports symptom management and potential regenerative strategies.
- Age-related neuronal vulnerability: Natural aging increases susceptibility of dopaminergic neurons, gradually raising Parkinson’s risk and worsening progression.
- Genetic mutations: Inherited gene changes and family history raise susceptibility to certain Parkinsonian syndromes.
- Environmental toxins: Pesticides, herbicides and chemicals can contribute to neuronal damage.
- Mitochondrial dysfunction and oxidative stress: Cellular energy failure and free radicals damage neurons, steadily accelerating neurodegeneration in susceptible individuals.
- Inflammation and immune responses: Chronic neuroinflammation, driven by microglial activation and systemic immune factors, promotes neuronal loss and disease propagation.
- Lifestyle and vascular factors: Head injury, poor cardiovascular health, and certain exposures influence disease onset and severity.
Early recognition and management of modifiable risks, alongside targeted regenerative approaches, may preserve function and slow progression. At Viezec, our regenerative medicine specialists personalize care based on each patient’s underlying mechanisms.
Symptoms of Parkinson’s Disease
Parkinson’s disease develops gradually, and early symptoms may be subtle or easily overlooked. Recognizing these signs at an early stage helps in managing the condition effectively and maintaining quality of life. Below are some of the most common symptoms noticed among individuals with Parkinson’s disease:
- ✅ Tremors or shaking, especially in hands or fingers
- ✅ Muscle stiffness or rigidity affecting movement
- ✅ Slowed movements (bradykinesia) making tasks take longer
- ✅ Impaired posture or balance issues
- ✅ Changes in speech, facial expressions, or handwriting
⚠️ Important: Consult a neurologist promptly if you notice persistent tremors, slowed movement, or stiffness. Early diagnosis and therapy can help slow disease progression and improve day-to-day function.
Diagnosis of Parkinson’s Disease
Accurate diagnosis of Parkinson’s Disease (PD) is crucial for early detection and optimal management. At Viezec, our specialists use comprehensive neurological assessment and advanced imaging to evaluate motor and non-motor signs, including gait, balance, sleep, and mood, and determine disease stage. Early differentiation from other movement disorders is essential for care.
Standard Diagnostic Tests Include:
- Neurological Examination: Detailed assessment of motor symptoms such as tremor, rigidity, bradykinesia, and postural instability.
- Magnetic Resonance Imaging (MRI): Imaging to rule out structural causes and assess brain changes.
- Dopamine Transporter (DaT) Scan: Functional imaging to evaluate dopamine system integrity and support diagnosis.
- Unified Parkinson’s Disease Rating Scale (UPDRS) and Levodopa Challenge: Quantifies symptoms, functional impact, and response to therapy.
🩺 Clinical Credibility: All PD diagnostic assessments at Viezec are conducted under the supervision of neurologists and movement disorder specialists following international guidelines. This ensures accurate staging, safety, and effective planning before any regenerative therapy or treatment is initiated.
Stem Cell Treatment for Parkinson’s Disease
How It Works
Stem cell therapy for Parkinson’s disease targets the progressive loss of dopaminergic neurons in the substantia nigra that underlies the characteristic motor symptoms. Transplantation of dopaminergic progenitors derived from pluripotent stem cells (iPSCs/ESCs) or mobilized mesenchymal stem cells aims to replace or support the failing neuronal network, supply neurotrophic factors, and reduce local inflammation. These cells can integrate, secrete protective molecules, and enhance synaptic function, which together may improve dopaminergic signaling, reduce neuronal stress, and restore circuitry that controls movement. The combined cell-replacement and paracrine effects contribute to slowing symptom progression and creating conditions that may enable measurable functional improvements in selected patients.
Procedure at Viezec
At Viezec, Parkinson’s treatments follow a multidisciplinary protocol developed by neurologists and regenerative medicine experts. Each step—from detailed neurological evaluation to long-term rehabilitation—is performed in GMP-certified facilities with strict quality controls to ensure cell safety, potency, and traceability throughout the therapy pathway.
- Comprehensive motor and cognitive assessments to determine eligibility
- Selection and preparation of autologous or allogeneic stem cell source
- Cell differentiation into dopaminergic progenitors and GMP processing
- Delivery via stereotactic intracerebral transplant, intrathecal, or intravenous route tailored to the clinical plan
- Post-procedure monitoring, physical therapy, and scheduled follow-ups
Expected Outcomes
Many patients experience stabilization of motor symptoms and modest improvements in tremor, rigidity, bradykinesia, or gait within 3–6 months after treatment. While stem cell therapies are not a guaranteed cure—particularly in advanced or long-standing disease—clinical experience suggests that regenerative approaches can slow symptomatic decline, reduce medication burden in some cases, and improve daily functioning and quality of life for a proportion of treated individuals.
Disclaimer: Outcomes depend on disease stage, patient age, overall neurological health, and prior treatments. Interventions at Viezec are performed under strict medical oversight and are intended to complement established neurologic care, not replace it.
Parkinson’s Disease (PD) Treatment
At Viezec, our regenerative cell therapy approach for Parkinson’s Disease concentrates on protecting and restoring neural function using safe, science-backed modalities. All cellular materials are handled in GMP-certified laboratories that meet ISO standards, guaranteeing consistent purity and biological viability prior to administration.
Each procedure is performed under specialist medical oversight employing targeted delivery techniques. The treatment plan is tailored to the patient’s clinical presentation and overall condition, encouraging neuronal support, functional recovery, and minimal procedural discomfort.
🧠 Our Safety & Quality Commitments Include:
- GMP, ISO, and NABL certified laboratory environments
- Ethically sourced — no embryo-derived or fetal cells used
- Full sterility and infection control throughout all procedures
- Ongoing neurologic evaluation and post-therapy care
Frequently Asked Questions
Can stem cell therapy cure Parkinson’s disease?
No. Stem cell therapy is not currently considered a cure for Parkinson’s disease. Researchers are investigating whether stem cells can help replace or support damaged dopamine-producing neurons, reduce inflammation, and improve neurological function. Some patients report improvements in movement, balance, tremors, and quality of life, but results vary from person to person. Stem cell therapy should be viewed as a potential supportive treatment rather than a guaranteed cure.
How does stem cell therapy work for Parkinson’s disease?
Stem cell therapy aims to support the repair of damaged nervous system tissues. Certain stem cells may release growth factors, reduce inflammation, and help create an environment that supports neuron survival. Researchers are also studying whether stem cells can develop into dopamine-producing cells that may help address some symptoms associated with Parkinson’s disease.
Who is a good candidate for Parkinson’s stem cell therapy?
Candidates are typically individuals diagnosed with Parkinson’s disease who continue to experience symptoms despite standard treatments. Eligibility depends on age, disease progression, medical history, current medications, and overall health. A comprehensive neurological evaluation is usually required before determining whether stem cell therapy may be appropriate.
What improvements do Parkinson’s patients report after stem cell therapy?
Reported improvements may include reduced tremors, better balance, improved walking ability, enhanced muscle control, reduced stiffness, and improvements in daily activities. However, outcomes vary widely, and some patients experience greater benefits than others. No clinic can accurately guarantee specific results.
Is stem cell treatment for Parkinson’s disease safe?
When performed by qualified medical professionals using established safety protocols, stem cell therapy is generally considered relatively safe. However, all medical procedures carry risks. Possible side effects may include temporary discomfort, infection, inflammation, or lack of therapeutic benefit. Patients should discuss risks and benefits with their medical team before treatment.
What type of stem cells are used for Parkinson’s disease treatment?
Different research programs and clinics may use different stem cell types. Commonly discussed options include mesenchymal stem cells (MSCs), neural stem cells, induced pluripotent stem cells (iPSCs), and other regenerative cell therapies. The choice depends on treatment goals, clinical protocols, and physician recommendations.
How long does it take to see results after stem cell therapy for Parkinson’s disease?
Some patients report noticing changes within weeks, while others may require several months before experiencing any improvements. Neurological recovery and tissue repair are gradual processes, and response times vary depending on disease severity, age, rehabilitation efforts, and overall health.
How many stem cell therapy sessions are needed for Parkinson’s disease?
The number of sessions varies depending on the patient’s condition, treatment protocol, and physician recommendations. Some treatment plans involve a single administration, while others may include multiple sessions combined with rehabilitation and follow-up evaluations.
Is stem cell therapy for Parkinson’s disease approved in India?
In India, stem cell therapy is approved for certain specific medical uses, such as some blood-related disorders. For many neurological conditions, including Parkinson’s disease, stem cell therapy is generally considered experimental and may be offered within specific clinical or regulated treatment frameworks. Patients should verify regulatory compliance and treatment details before proceeding.
What is the success rate of stem cell therapy for Parkinson’s disease?
There is currently no universally accepted success rate for stem cell therapy in Parkinson’s disease. Clinical studies have shown promising results for some patients, particularly regarding symptom improvement and quality of life. However, outcomes differ significantly among individuals, and additional research is still underway.
Can stem cell therapy replace Parkinson’s medications?
In most cases, stem cell therapy is not intended to replace prescribed Parkinson’s medications. Many patients continue using medications while receiving supportive regenerative therapies. Any medication changes should only be made under the supervision of a neurologist.
What tests are required before Parkinson’s stem cell treatment?
Patients commonly undergo neurological assessments, medical history reviews, laboratory testing, imaging studies such as MRI scans, medication evaluations, and physical examinations. These assessments help determine eligibility and establish treatment goals.
Can international patients travel to India for Parkinson’s stem cell therapy?
Yes. Many international patients travel to India for stem cell therapy because of the country’s medical infrastructure, specialist expertise, and comparatively lower treatment costs. Treatment providers often assist with consultations, medical coordination, accommodation guidance, and follow-up planning.
What are the risks of stem cell therapy for Parkinson’s disease?
Potential risks may include infection, inflammation, immune reactions, procedural complications, or failure to achieve the desired outcome. Long-term effects continue to be studied, which is why patients should seek treatment from experienced providers that follow established safety standards.
Is there scientific research supporting stem cell therapy for Parkinson’s disease?
Yes. Researchers worldwide are actively studying stem cell therapy for Parkinson’s disease. Early-stage studies and clinical trials have shown encouraging results regarding safety and symptom improvement. However, larger and longer-term studies are still needed to determine effectiveness and long-term outcomes.
For additional information about Parkinson’s disease stem cell therapy, treatment eligibility, safety considerations, and international patient services, please contact our regenerative medicine team for a personalized consultation.
How Much Does Stem Cell Therapy Cost for Parkinson’s Disease?
The cost of stem cell therapy for Parkinson’s disease varies depending on the patient’s stage of Parkinsonism, the type of stem cells used (such as MSCs or neural stem cells), number of treatment sessions, and the expertise of the medical center. Costs also differ globally due to variations in healthcare systems, infrastructure, and regulatory standards. Below is a country-wise comparison to understand how the expenses typically range.
Cost Comparison: Select Countries
The table below represents approximate cost ranges reported by clinics and international patients for a comprehensive stem cell therapy program, including medical evaluation, lab processing, cell transplantation, and post-therapy care.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $22,000 – $38,000 | ₹18,20,000 – ₹31,40,000 |
| United Kingdom 🇬🇧 | $17,000 – $27,000 | ₹14,00,000 – ₹22,30,000 |
| Germany 🇩🇪 | $20,000 – $30,000 | ₹16,50,000 – ₹24,80,000 |
| Singapore 🇸🇬 | $14,000 – $23,000 | ₹11,50,000 – ₹19,00,000 |
While developed countries such as the USA, UK, and Germany offer advanced medical setups, the overall treatment expenses are significantly higher due to costly hospital operations and medical labor. In contrast, India has emerged as a leading destination for affordable and effective stem cell therapy for Parkinson’s disease, offering comparable standards of medical excellence at a fraction of the cost.
India’s lower treatment cost is attributed to reduced operational costs, favorable exchange rates, and efficient healthcare delivery models — without compromising on quality or outcomes. Reputed Indian hospitals employ internationally trained doctors, GMP-certified laboratories, and globally approved treatment protocols to ensure optimal safety and results for Parkinson’s patients.
Why Choose Viezec?
Viezec partners with leading regenerative medicine centers that specialize in neurological disorders like Parkinson’s disease. We ensure that every patient receives ethical, transparent, and world-class medical care — from consultation to follow-up rehabilitation — all aligned with global healthcare standards.
Get a Personalized Cost Estimate
Each Parkinson’s case is unique. Contact our medical team to get a personalized quotation and a customized treatment roadmap based on your specific health profile and progression stage.
Improvements & Results
Based on patient follow-ups at Viezec, many individuals treated for Parkinson’s disease (PD) have reported measurable gains in motor control, daily functioning, and quality of life. Our multidisciplinary team tracks functional outcomes through scheduled neurological assessments to ensure improvements are safe and sustained.
Improved Motor Function
A majority of patients reported gradual reductions in tremor severity and smoother limb movements within 3–6 months after therapy, enabling easier performance of routine tasks. Learn more about PD outcomes.
Better Mobility & Balance
Patients commonly report improved gait stability and confidence when walking, with fewer episodes of freezing and improved ability to navigate daily environments.
Stabilized Progression
Ongoing monitoring demonstrates that many patients show slowed functional decline and sustained improvements on follow-up neurological scales and functional tests.
Patient Experiences
“Within a few months my hand tremors reduced — I can tie my shoes and write legibly again. Daily tasks feel much more manageable and stable.”
– Patient from Mumbai, India
“The therapy helped my walking and confidence — I feel steadier on my feet and less anxious about going out alone.”
– Patient from Abu Dhabi
Mechanism of Action: How Stem Cells Aid Neural Repair in Parkinson’s Disease
Stem cell therapy for Parkinson’s Disease (PD) focuses on replenishing lost dopaminergic neurons and improving motor control. Rather than only replacing damaged nerve cells, stem cells act as biological modulators—secreting neurotrophic factors, anti-inflammatory agents, and antioxidants that foster a healthier neural environment. This regenerative mechanism helps slow neuronal loss and supports functional recovery over time.
- Neuronal Regeneration: Stem cells can differentiate into dopaminergic-like neurons that restore dopamine balance in the brain.
- Neuroinflammation Control: They help regulate inflammatory responses that accelerate neuronal degeneration in the substantia nigra.
- Neuroprotective Support: Stem cells secrete growth and survival factors that protect existing neurons and enhance synaptic function.
- Oxidative Stress Reduction: By releasing antioxidants and protective molecules, stem cells mitigate oxidative injury to brain tissues.
This comprehensive biological action underscores the potential of mesenchymal stem cells (MSCs) in addressing both motor and non-motor symptoms of Parkinson’s Disease. At Viezec, each therapy is conducted under strict clinical oversight to maintain safety, therapeutic precision, and ethical compliance throughout the treatment journey.
Parkinson’s Disease
At Viezec, our regenerative treatment programs for Parkinson’s Disease aim to support and rejuvenate damaged neural pathways through scientifically designed stem cell therapies and personalized neurological care plans. Our goal is to help improve motor function, enhance brain health, and slow disease progression with the highest degree of precision and compassion.
We focus on realistic outcomes supported by clinical research and technological innovation — not exaggerated claims. Our skilled neurology specialists, accredited partner hospitals, and structured follow-up care ensure that every patient receives treatment aligned with global safety and ethical standards.
Treatment Results
Patients who undergo stem cell therapy for Parkinson’s Disease at Viezec frequently report measurable improvements such as reduced tremor intensity, improved bradykinesia (slowness of movement), better postural stability, and easier performance of everyday tasks. The extent of benefit depends on disease stage, degree of neuronal loss, and each patient’s general health.
Careful follow-ups using standardized neurological scales (for example, UPDRS), motor assessments, and imaging studies enable precise tracking of clinical changes and help guide individualized rehabilitation. Recovery timelines differ, but many patients perceive functional gains and improved quality of life within 6–12 months after treatment.
At Viezec, we strive to provide advanced regenerative options; however, we do not promise specific outcomes or a cure. Stem cell therapy effects vary with individual biology and disease characteristics. Since each patient responds differently, it is important to recognise that stem cell therapy for Parkinson’s disease remains research-focused with variable results and no guaranteed success.
Testimonials
Richard H. – New York, USA – January 2020 – ⭐⭐⭐⭐☆
“Parkinson’s tremors limited my daily life. After stem cell therapy at Viezec, my hand stability improved, and I regained confidence in small tasks.”
Anil K. – Pune, India – May 2020 – ⭐⭐⭐⭐⭐
“My father’s stiffness reduced significantly after treatment. Viezec’s team gave us care and hope, and his walking has improved noticeably.”
Maria L. – Lisbon, Portugal – October 2021 – ⭐⭐⭐⭐☆
“I struggled with balance and coordination. Post-therapy at Viezec, I can walk more steadily and feel less dependent on support.”
Hassan M. – Doha, Qatar – December 2021 – ⭐⭐⭐⭐⭐
“My tremors reduced and daily chores became easier after stem cell therapy. Viezec’s doctors guided us every step with professionalism.”
Olivia S. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐☆
“Before therapy, fatigue and slowness dominated my days. Thanks to Viezec, I now have more energy and better control over movements.”
Ahmed R. – Cairo, Egypt – July 2022 – ⭐⭐⭐⭐⭐
“Stem cell treatment at Viezec gave me improved speech clarity and reduced stiffness. My quality of life has greatly improved.”
Sophie D. – Paris, France – April 2023 – ⭐⭐⭐⭐☆
“I had difficulty with simple activities due to Parkinson’s. After Viezec’s therapy, my mobility increased, and I feel more independent.”
George K. – Sydney, Australia – September 2023 – ⭐⭐⭐⭐⭐
“The shaking in my hands eased after therapy. With physiotherapy and Viezec’s support, I can now write legibly again.”
Fatima H. – Dubai, UAE – March 2024 – ⭐⭐⭐⭐☆
“My husband’s movements became smoother, and his walking speed improved after treatment at Viezec. It gave our family new hope.”
Carlos M. – Madrid, Spain – June 2025 – ⭐⭐⭐⭐⭐
“Viezec’s stem cell therapy helped me manage tremors and stiffness. Daily life feels easier, and I feel optimistic about the future.”
Success Rates & Patient Outcomes — Parkinson’s Disease
At Viezec, our work on neuroregeneration for Parkinson’s Disease (PD) is guided by careful clinical follow-ups, standardised motor and non-motor assessments, and patient-reported measures of daily function. Treatments are integrated into structured post-therapy rehabilitation programmes so recovery, functional gains and quality-of-life changes are routinely measured and reviewed.
The observed clinical response to stem cell approaches for PD varies with cell type, disease stage, delivery method and rehabilitation adherence. Across recent systematic reviews and early clinical series, patients commonly show functional motor improvement in approximately 60–85% of treated cases, with some small studies reporting higher point estimates but limited sample sizes. These improvements include reduced bradykinesia, tremor attenuation and better performance in daily activities.
All interventions we reference are performed under clinical trial protocols or in GMP-grade facilities when applicable. Early phase trials of iPSC/hESC-derived dopaminergic progenitors and well-controlled MSC studies have reported acceptable safety profiles and encouraging signals of efficacy at 6–12 months, though longer term durability is still being studied. Ongoing high-quality trials continue to refine dosing, cell source and surgical technique.
~70%
Reported Motor Function Gain (approx.)
85%
Overall Patient-Reported Benefit (small series)
Treatment Disclaimer
The content on this page discusses Parkinson’s Disease and possible management approaches solely for informational and educational purposes. It is not intended to substitute for professional medical consultation, diagnosis, or care. Every patient’s symptom pattern, progression, and response to therapy are unique; the general descriptions provided here may not fully apply to your individual case.
Viezec facilitates medically guided services based on current research, neurological standards, and clinical experience, but we cannot guarantee specific functional outcomes. Treatment decisions should always be made with a qualified neurologist or movement-disorders specialist familiar with your diagnostic findings and medical background.
- What this page does: Provides insight into Parkinson’s causes, available management options, and realistic expectations.
- What this page does not do: Offer individualized medical advice or replace an in-person neurological assessment.
- If symptoms suddenly worsen: Seek prompt evaluation from a neurologist or visit emergency services.
For tailored recommendations, please request a professional neurological evaluation. Our medical team performs a comprehensive review before suggesting any management approach.
What to expect in a professional evaluation
- Detailed review of neurological and general medical history along with movement assessment and diagnostic imaging or tests if indicated.
- Discussion of evidence-based Parkinson’s management options, medication strategies, rehabilitative therapies, and potential benefits and risks.
- Comprehensive informed consent and individualized care planning before initiating any intervention.
Conclusion
In conclusion, Parkinson’s Disease is a progressive neurological disorder that significantly impacts movement, balance, and overall quality of life. Diagnosing this condition requires a detailed neurological assessment, medical history review, and evaluation of characteristic symptoms such as tremors, rigidity, and bradykinesia. Early detection and personalized treatment play a vital role in slowing disease progression and improving patient outcomes.
Stem cell therapy has emerged as a promising regenerative approach for Parkinson’s Disease, offering potential benefits that go beyond traditional medications. By replacing damaged neurons and restoring dopamine production, stem cell treatment aims to address the root cause of the disease rather than just managing symptoms. When performed under expert medical supervision at accredited centers in India, stem cell therapy may improve motor function, enhance cognitive abilities, and support long-term neurological recovery.
With continuous advancements in regenerative medicine, ongoing clinical studies, and growing accessibility of treatment options in India, stem cell therapy provides renewed hope for individuals living with Parkinson’s Disease. Combining innovative medical technology with comprehensive care and rehabilitation can pave the way for better management and improved quality of life for patients worldwide.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
